Day 1 , 26 August 2026

Breaking down the barriers between the virtual and physical, thought leadership sessions will showcase the latest and proven integration of AI technologies with hardware, enhancing the effectiveness of human action across industries and real-world use cases.

AI is no longer confined to simulations or software. This session explores how embodied AI integrates perception, decision-making, and actuation to create autonomous systems capable of interacting safely and effectively in dynamic environments. Use cases span industrial automation, robotics-assisted healthcare, and smart infrastructure.

As embodied AI enters shared human environments, regulatory frameworks, safety protocols, and liability models are crucial. This panel discusses governance, cybersecurity, and public trust in AI-enabled hardware across industries.

Robots and AI-enabled tools are augmenting, not replacing, human capabilities. This session examines collaborative robotics (cobots), AI-driven assistance, and intelligent decision-support systems across manufacturing, logistics, and healthcare, showcasing how AI enhances safety, efficiency, and productivity.

Many robotics and AI projects fail to scale. This panel explores integration challenges, workforce adoption, ROI measurement, and best practices for deploying robotics across warehouses, hospitals, factories and workplaces.

From autonomous vehicles to urban infrastructure management, AI-enabled technologies are transforming operational efficiency at scale. This session explores deployment strategies, interoperability, and safety frameworks for autonomous systems in smart cities, transportation, and industrial environments.

Can ASEAN develop its own Embodied AI ecosystem, or will the region remain dependent on imported solutions? This panel discusses talent development, funding, government incentives, and cross-border collaboration for a sustainable Embodied AI industry.

Explore how AI is transforming the delivery of healthcare and accelerating biomedical research, from optimising clinical workflows to enabling precision medicine. This track showcases the latest AI-driven solutions revolutionising care delivery, pharmaceuticals, and diagnostics.

AI enables faster and more accurate analysis of complex genomic, proteomic, and clinical datasets, powering precision diagnostics and personalised treatment strategies. This session will highlight case studies in oncology, rare diseases, and predictive risk assessment, demonstrating clinical and commercial impact.

How can regulators foster innovation while ensuring patient safety? Panelists will discuss AI validation standards, transparency, clinical accountability, and cross-border regulatory alignment in ASEAN and Singapore.

Hospitals are leveraging AI to streamline patient triage, radiology and pathology workflows, and hospital resource allocation. This session explores integration into EMRs, clinician adoption, regulatory validation, and how AI is improving patient outcomes while reducing operational costs.

Many AI initiatives stall at pilot stage. This panel explores integration, workforce adaptation, procurement, and ROI measurement to ensure AI projects deliver enterprise-wide impact across hospitals, diagnostics, and pharma.

AI is revolutionising pharmaceutical R&D by improving target identification, compound screening, and trial design, significantly reducing development timelines and costs. This session covers real-world applications, clinical validation, and the regulatory considerations of AI-enabled drug discovery.

ASEAN has the potential to become a biomedical AI hub. This panel discusses cross-border clinical trials, data-sharing frameworks, talent mobility, and regional funding mechanisms to accelerate innovation in healthtech.

* Programme accurate as of 08 March 2026.